Developing a vaccine against Sudan virus disease
- PMID: 37544325
- DOI: 10.1016/S1473-3099(23)00360-2
Developing a vaccine against Sudan virus disease
Conflict of interest statement
I report grants to my institution from Innovative Health Initiative, outside the submitted work.
Comment on
-
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.Lancet Infect Dis. 2023 Dec;23(12):1408-1417. doi: 10.1016/S1473-3099(23)00344-4. Epub 2023 Aug 3. Lancet Infect Dis. 2023. PMID: 37544326 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
